State Court Activity
Parallel state court filings in multiple jurisdictions; federal venue consolidation preferred by defendants
Environmental · claims that chronic benzene exposure from consumer products, industrial workplaces, or contaminated environments causes leukemia, lymphoma, and other blood cancers
Defendant
The 3M Company
MDL / Track
No MDL established
S.D.N.Y. (emerging consolidation hub)
Judge
Plaintiffs
Six class actions pending against L'Oréal over CeraVe benzene claims as of July 2026
Bellwether / Trial
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
Benzene exposure litigation in 2026 operates on two parallel tracks: historic occupational claims against petroleum and chemical majors and a 2021-2024 consumer-product wave triggered by Valisure independent-laboratory testing. The consumer track encompasses recalls of Johnson & Johnson Neutrogena/Aveeno sunscreens (May 2021), Procter & Gamble Old Spice/Secret antiperspirants (November 2021), Unilever dry shampoos (October 2022), Edgewell Banana Boat sunscreen (July 2022), and Pfizer Anbesol (2023). In Dickerson v. CRC Industries, Inc., No. 2:25-cv-00014 (E.D.N.C. July 2025), Judge Terrence W. Boyle denied Exxon Mobil's motion to dismiss, holding that North Carolina's statute of repose does not bar disease-based benzene claims and that MDS claims accrue at diagnosis, not exposure. In Bowen v. Energizer Holdings, Inc., No. 23-55116 (9th Cir. Oct. 1, 2024), the Ninth Circuit reversed dismissal for lack of standing, recognizing overpayment theory injury where plaintiff alleged she would not have purchased Banana Boat sunscreen had benzene contamination been disclosed. Personal injury claims are consolidated in the Southern District of Florida MDL, with discovery ongoing and no bellwether trials reported as of mid-2025.
Causation Theory
Benzene is classified as a Group 1 carcinogen by the International Agency for Research on Cancer and the U.S. Environmental Protection Agency. Accepted benzene-linked malignancies include acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphocytic leukemia (ALL), non-Hodgkin lymphoma (NHL), myelodysplastic syndromes (MDS), aplastic anemia, and multiple myeloma. In consumer products, benzene contamination has been detected in aerosol sunscreens and personal care products through independent laboratory testing. A March 2021 study in Chemical Research in Toxicology established that benzophenone, a distinct compound from benzene, accumulates over time from octocrylene degradation in sunscreen products, with concentrations increasing under FDA-accelerated stability aging protocols; up to 70% of benzophenone in these products may be absorbed through the skin.
Litigation status
Benzene litigation operates on two active tracks: mature occupational exposure claims and rapidly expanding consumer product cases. The consumer product track accelerated following Valisure testing revelations and now includes multiple pending class actions against L'Oréal/CeraVe over benzoyl peroxide acne treatments; six class actions are pending per July 2026 reporting. Federal venue consolidation is underway in the Southern District of New York, where at least five related cases are now centralized. The 11th Circuit vacated and remanded the Johnson & Johnson sunscreen settlement in June 2024 for application of Drazen v. Pinto's coupon-settlement standards.
State Court Activity
Parallel state court filings in multiple jurisdictions; federal venue consolidation preferred by defendants
Geographic exposure
119 US refineries under EPA fenceline monitoring rule 2018–2023; national mean refinery benzene declined to 3.2 µg m−3 by 2023 but Texas-Louisiana corridor persists at 5× Western states. >25 million consumer sunscreen units recalled for benzene contamination. Fenceline communities in Gulf Coast petrochemical corridor face sustained elevated exposure with documented cancer clusters.
Statewide refinery fenceline benzene concentrations highest in nation at mean 6.5 µg m−3 (95% CI: 4.6–8.5), 5× California levels; 14 refineries monitored 2018–2023 per EPA fenceline rule. Port Arthur fenceline communities at Texas-Louisiana border bear concentrated exposure. Source: Environmental Research Letters, Peters et al., April 2026; Texas Tribune, April 23, 2026
Statewide refinery fenceline mean benzene 6.1 µg m−3 (95% CI: 4.8–7.4), second-highest nationally; 28 refineries, 9 of 20 worst polluters nationally. TotalEnergies Refinery Port Arthur ranked 3rd highest benzene levels nationwide. 2023 levels remained elevated at 5.1 µg m−3 despite national decline. Channelview fenceline community showed 'significantly greater than expected' leukemia and lymphoma rates per 2025 state data. Texas long-term benzene exposure limit 1.4 ppb vs. 0.03 ppb Massachusetts. Source: Environmental Research Letters, April 2026; Texas Tribune, April 23, 2026
Dense petrochemical infrastructure creates 'unique exposure rate' per Fenceline Watch; fenceline communities experience regular uncontrolled benzene releases from flaring, leaks, explosions. Source: Texas Tribune, April 23, 2026
Navajo Refinery identified as single highest benzene polluter among 119 US refineries in 2018–2023 fenceline monitoring dataset. Source: Environmental Research Letters, Peters et al., April 2026; Texas Tribune, April 23, 2026
Statewide refinery fenceline mean benzene 1.0 µg m−3 (95% CI: 0.7–1.3), lowest nationally; 12 refineries. Distribution consistently below national median throughout 2018–2023. Source: Environmental Research Letters, Peters et al., April 2026
Statewide refinery fenceline mean benzene 1.2 µg m−3, second-lowest nationally; maintained below-national-median performance 2018–2023. Source: Environmental Research Letters, Peters et al., April 2026
Valisure detected benzene in 78 sunscreen/after-sun products; >25 million aerosol spray units recalled including Neutrogena, Aveeno, Coppertone, Banana Boat. Contamination source: manufacturing/propellant supply chain, not active ingredients. Aerosol sprays create inhalation plus dermal exposure pathway. Source: AMOverview, July 12, 2026
Key defendants
The 3M Company
Role: Manufacturer
Removed to SDNY (1:25-cv-06724) under federal officer jurisdiction; no corporate parent per Rule 7.1 disclosure. Early posture, no dispositive motion activity yet.
Exxon Mobil
Role: Petroleum Refiner
Motion to dismiss denied July 2025 in Dickerson v. CRC Industries (E.D.N.C.); court rejected statute of repose defense for disease-based MDS claims. Exposure now merits-phase.
PBF Energy Inc.
Role: Refinery Operator
Named in N.D. Cal. class action (3:23-cv-06142) with Martinez Refining Co. subsidiary; claims include Clean Air Act violations, medical monitoring, and ultrahazardous activity. Active discovery posture.
Martinez Refining Company LLC
Role: Refinery Subsidiary
Co-defendant with PBF Energy in N.D. Cal. benzene emissions class action; allegations of unreported toxic releases from November 2022 incident. No dismissal motion filed per docket.
| Defendant | Role | Intelligence Note |
|---|---|---|
| The 3M Company | Manufacturer | Removed to SDNY (1:25-cv-06724) under federal officer jurisdiction; no corporate parent per Rule 7.1 disclosure. Early posture, no dispositive motion activity yet. |
| Exxon Mobil | Petroleum Refiner | Motion to dismiss denied July 2025 in Dickerson v. CRC Industries (E.D.N.C.); court rejected statute of repose defense for disease-based MDS claims. Exposure now merits-phase. |
| PBF Energy Inc. | Refinery Operator | Named in N.D. Cal. class action (3:23-cv-06142) with Martinez Refining Co. subsidiary; claims include Clean Air Act violations, medical monitoring, and ultrahazardous activity. Active discovery posture. |
| Martinez Refining Company LLC | Refinery Subsidiary | Co-defendant with PBF Energy in N.D. Cal. benzene emissions class action; allegations of unreported toxic releases from November 2022 incident. No dismissal motion filed per docket. |
Timeline
Valisure Petitions FDA on Benzene in Sunscreens
Independent laboratory Valisure files citizen petition with FDA requesting recalls of benzene-contaminated sunscreens, triggering wave of consumer-product litigation. Testing found benzene in 78 sunscreen and after-sun care products.
J&J Recalls Neutrogena, Aveeno Sunscreens
Johnson & Johnson Consumer Inc. issues voluntary nationwide recall of five aerosol sunscreen lines after internal testing detects benzene. Recall covers Neutrogena Beach Defense, Cool Dry Sport, Invisible Daily Defense, Ultra Sheer, and Aveeno Protect + Refresh.
MDL 3015 Formed for J&J Sunscreen Litigation
Judicial Panel on Multidistrict Litigation consolidates Johnson & Johnson aerosol sunscreen cases into MDL No. 3015, assigned to Judge Anuraag Singhal in the Southern District of Florida.
$725.5M Verdict Against ExxonMobil in AML Case
Philadelphia Court of Common Pleas jury awards $725.5 million to former mechanic with acute myeloid leukemia linked to benzene exposure in solvents. Verdict upheld September 2024 with damages increased to $816 million.
Ninth Circuit Revives Banana Boat False Advertising Suit
Ninth Circuit reverses dismissal in Bowen v. Energizer Holdings, No. 23-55116, holding plaintiff has Article III standing to pursue false advertising claims over benzene contamination in Banana Boat sunscreen despite FDA's 2 ppm guidance.
E.D.N.C. Denies Exxon Repose Defense in MDS Case
U.S. District Court for Eastern District of North Carolina denies Exxon Mobil's motion to dismiss in Dickerson v. CRC Industries, Inc., et al., allowing myelodysplastic syndrome claims to proceed. Court rejects statute of repose defense under N.C. Gen. Stat. §§ 1-50(a)(6) and 1-52(16), holding disease claims accrue at diagnosis (2017) not exposure end (2006).
MDL 2994 Bellwether Trials Scheduled
Consumer sunscreen personal injury cases in MDL 2994 (S.D. Fla.) proceed to bellwether trials scheduled for late 2026. Class action settlement largely resolved; individual injury claims for AML, MDS, and leukemia diagnoses remain active.
Statute of limitations
FDA 2 ppm guidance for unavoidable benzene in drugs distinguishes sunscreen as elective cosmetic use—supports failure-to-warn theories. IARC March 2025 reclassification of automotive gasoline as Group 1 carcinogen strengthens causation evidence. No nationwide tolling agreement identified.
North Carolina
3 years from diagnosis
Rule: Disease claims accrue at diagnosis, not exposure; statutes of repose held inapplicable to latent disease claims per Dickerson v. CRC Industries, Inc., et al., E.D.N.C. July 2025 (citing Dunn v. Pacific Employers Insurance Co., 1992; Wilder v. Moore, 1994; Stahle v. CTS Corp., 4th Cir.)
Discovery: Accrual at diagnosis of benzene-related illness (MDS, AML, aplastic anemia), not at end of exposure
Federal court rejected 6- and 10-year repose defenses under N.C. Gen. Stat. §§ 1-50(a)(6) and 1-52(16). Exposure ending in 2006; diagnosis 2017; filing 2019 held timely.
California
2 years from discovery of injury
Rule: Discovery rule applies; Bowen v. Energizer Holdings, Inc., 2024 WL 4352496 (9th Cir. Oct. 1, 2024) recognized Article III standing for benzene sunscreen consumer claims
9th Circuit remanded for merits determination on safety allegations; consumer benzene exposure claims remain viable.
Florida
4 years from injury
Rule: Discovery rule applies for latent diseases; MDL 2994 (Benzene Sunscreen) centralized in S.D. Fla.
Discovery: Accrual tied to diagnosis or when disease becomes apparent, not exposure date
MDL 2994 active as of January 2026. Personal injury track proceeding to trial 2026-2027. Class action settlement largely resolved; individual injury claims remain viable. Screen for: AML, MDS, leukemia diagnoses with sunscreen use 2021-2022 recall period.
Illinois
2 years from discovery of injury
Rule: 735 ILCS 5/13-202; discovery rule applies for toxic torts with latency periods
Discovery: Accrual when plaintiff knows or reasonably should know of injury and its cause
Pennsylvania
2 years from discovery of injury
Rule: 42 Pa.C.S. § 5524(2); discovery rule applies for latent diseases
Discovery: Accrual upon discovery of injury and factual basis for causation
Dickerson originally filed in Philadelphia County 2019; dismissed for jurisdictional reasons. North Carolina refile held timely.
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| North Carolina | 3 years from diagnosis | Disease claims accrue at diagnosis, not exposure; statutes of repose held inapplicable to latent disease claims per Dickerson v. CRC Industries, Inc., et al., E.D.N.C. July 2025 (citing Dunn v. Pacific Employers Insurance Co., 1992; Wilder v. Moore, 1994; Stahle v. CTS Corp., 4th Cir.) | Accrual at diagnosis of benzene-related illness (MDS, AML, aplastic anemia), not at end of exposure | Federal court rejected 6- and 10-year repose defenses under N.C. Gen. Stat. §§ 1-50(a)(6) and 1-52(16). Exposure ending in 2006; diagnosis 2017; filing 2019 held timely. |
| California | 2 years from discovery of injury | Discovery rule applies; Bowen v. Energizer Holdings, Inc., 2024 WL 4352496 (9th Cir. Oct. 1, 2024) recognized Article III standing for benzene sunscreen consumer claims | — | 9th Circuit remanded for merits determination on safety allegations; consumer benzene exposure claims remain viable. |
| Florida | 4 years from injury | Discovery rule applies for latent diseases; MDL 2994 (Benzene Sunscreen) centralized in S.D. Fla. | Accrual tied to diagnosis or when disease becomes apparent, not exposure date | MDL 2994 active as of January 2026. Personal injury track proceeding to trial 2026-2027. Class action settlement largely resolved; individual injury claims remain viable. Screen for: AML, MDS, leukemia diagnoses with sunscreen use 2021-2022 recall period. |
| Illinois | 2 years from discovery of injury | 735 ILCS 5/13-202; discovery rule applies for toxic torts with latency periods | Accrual when plaintiff knows or reasonably should know of injury and its cause | — |
| Pennsylvania | 2 years from discovery of injury | 42 Pa.C.S. § 5524(2); discovery rule applies for latent diseases | Accrual upon discovery of injury and factual basis for causation | Dickerson originally filed in Philadelphia County 2019; dismissed for jurisdictional reasons. North Carolina refile held timely. |
Live intelligence
AI litigation brief
Benzene Exposure remains active litigation category with 32 current signals in the accepted feed.
Overview
Benzene litigation operates on two active tracks: mature occupational exposure claims and rapidly expanding consumer product cases. The consumer product track accelerated following Valisure testing revelations and now includes multiple pending class actions against L'Oréal/CeraVe over benzoyl peroxide acne treatments; six class actions are pending per July 2026 reporting. Federal venue consolidation is underway in the Southern District of New York, where at least five related cases are now centralized. The 11th Circuit vacated and remanded the Johnson & Johnson sunscreen settlement in June 2024 for application of Drazen v. Pinto's coupon-settlement standards.
Key developments
Trajectory
Press and regulatory signals are moving in tandem for Benzene Litigation. The next escalation check is whether these agency actions prompt new PACER filings or MDL scheduling orders.
Editorial intelligence
Editorial coverage should stay tied to source-backed developments and avoid placeholder status copy for Benzene Litigation.
Generated Aug 12, 2026, 3:00 AM UTC
32 events detected
Google News (19)
CeraVe Lawsuit 2026: Payouts (Updated July 2026) - LawFold.com
CeraVe benzene cancer lawsuit: The truth about the products, the 2026 recall rumours and the risks - Mamabella
L'Oréal faces six class actions over CeraVe cancer risk claims - Yeni Safak English
UK Regulators Expose Toxic Benzene in Imported Children's Toys Following Urgent Recall - streamlinefeed.co.ke
Benzene in CeraVe? Separating skincare science from internet hysteria - IOL
Leukemia Lawsuit: Payouts, Eligibility, 2026 Guide - LawFold.com
L’Oreal-owned CeraVe skincare product faces multiple lawsuits over cancer-causing chemical claims - Peoples Gazette Nigeria
CeraVe named in viral cancer claims, FDA tests products after Benzene fears - AOL.com
A Look At L'Oréal (ENXTPA:OR) Valuation After CeraVe Benzene Lawsuits Raise Product Safety Concerns - simplywall.st
Petition to recall ‘carcinogenic’ products - Daily Tribune
Target recalls baby wipes over bacterial contamination - Personal Care Insights
CeraVe Parent Company Faces Multiple Lawsuits Over Benzene Claims In Acne Products - LEADERSHIP Newspapers
L'Oréal-owned CeraVe faces 6 class action lawsuits over claims products contain cancer-causing chemical - Snopes
Aamjiwnaang seeks accountability from INEOS over alleged benzene exposure - The Sarnia Journal
From Skincare Staple to Cancer-Fear Controversy: How CeraVe Became the Face of Benzene- Cancer Debate - Medical Dialogues
CeraVe faces 6 lawsuits over Benzene, cancer causing carcinogen found in acne cream - Geo News
Johnson and Johnson Sunscreen Lawsuit in 2026: Guide - LawFold.com
CeraVe Lawsuit 2026: Payouts, Claims & Who Qualifies - LawFold.com
Benzene Lawsuit in 2026: Settlements and Key Updates - LawFold.com
No recent PubMed signals. Monitoring is active — this section updates automatically.
The EPA proposes a cleanup plan for benzene and other chemical contamination at a former pesticide manufacturing Superfund site in New Jersey, where historical benzene exposure poses cancer risks to nearby residents and workers.
EPA News Release regulatory on Jun 15 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
The EPA is proposing a cleanup plan for the Orlando Gasification Superfund Site, which involves benzene contamination in the environment. This relates to benzene exposure claims as it documents government-recognized benzene contamination requiring remediation, potentially supporting environmental exposure litigation theories.
EPA News Release regulatory on Apr 7 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
This EPA Superfund site profile documents groundwater contamination in Levelland, Texas, where benzene and other chemicals have polluted the environment, creating potential exposure risks to local residents that could support blood-cancer claims tied to chronic benzene exposure.
EPA Superfund regulatory on Mar 30 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
CHARLES GEORGE RECLAMATION TRUST LANDFILL | Superfund Site Profile | Superfund Site Information | US EPA Superfund Information Systems: Site Profile ## Superfund Site: ## CHARLES GEORGE RECLAMATION TRUST LANDFILLTYNGSBOROUGH, MA ## Contaminant List Sign up for this Superfund site’s mailing list EPA has identified the chemical substances (i.e., hazardous substances, pollutants or contaminants) list
EPA Superfund regulatory on Mar 25 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
EL TORO MARINE CORPS AIR STATION | Superfund Site Profile | Superfund Site Information | US EPA Superfund Information Systems: Site Profile ## Superfund Site: ## EL TORO MARINE CORPS AIR STATIONEL TORO, CA ## Contaminant List EPA has identified the chemical substances (i.e., hazardous substances, pollutants or contaminants) listed below as contaminants of concern (COCs) for the site. COCs are the
EPA Superfund regulatory on Mar 25 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
No recent court filing signals. Monitoring is active — this section updates automatically.
No recent legislative signals. Monitoring is active — this section updates automatically.
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
46Score
Fresh items are present but not yet surging
Monitoring
Live
monitoring
Last: Aug 12, 2026, 3:00 AM UTC
Next: —
Source Monitoring
PACER
PACER
Google News
PubMed
EPA
Event feed
32
events detected
AI Brief
Benzene Exposure remains active litigation category with 32 current signals in the accepted feed.
Overview
Benzene litigation operates on two active tracks: mature occupational exposure claims and rapidly expanding consumer product cases. The consumer product track accelerated following Valisure testing revelations and now includes multiple pending class actions against L'Oréal/CeraVe over benzoyl peroxide acne treatments; six class actions are pending per July 2026 reporting. Federal venue consolidation is underway in the Southern District of New York, where at least five related cases are now centralized. The 11th Circuit vacated and remanded the Johnson & Johnson sunscreen settlement in June 2024 for application of Drazen v. Pinto's coupon-settlement standards.
Key developments
LawFold.com news on Jul 16: CeraVe Lawsuit 2026: Payouts (Updated July 2026) - LawFold.com. ‖ EPA News Release regulatory on Jun 15: EPA Proposes Cleanup Plan to Address Contamination on Properties at the Former Kil-Tone Co. Superfund Site Floodplain in Vineland, New Jersey.
Generated Aug 12, 2026, 3:00 AM UTC
← Previous
Baby Food Heavy Metals
Tracks product-liability litigation, FDA enforcement, and neurodevelopmental research tied to toxic heavy metals in commercial baby food products.
Next →
Discord Sexual Abuse
Tracks platform-design liability litigation and policy activity tied to Discord-facilitated grooming, exploitation, and sexual abuse of minors.